top of page

Diagnosed with PD before 55 - try Mucuna first.

Writer's picture: Macudopa teamMacudopa team



If you've been diagnosed with Parkinson's disease when you're under 55 years old, the goal of your treatment is to delay the use of levodopa medications like Sinemet, Madopar, or Stalevo for as long as possible. Instead, your doctor may suggest using medications like rasagiline (Azilect) or dopamine agonists such as pramipexole (Mirapex), rotigotine (Neupro patches), or ropinirole.


Later on, when you do need levodopa, you and your doctor can discuss the option of starting with the HPLC standardised mucuna pruriens in MacuDopa. This choice is often considered because it's associated with fewer long-term movement issues (dyskinesia). But remember, it's a decision you should make together with your doctor.


If you're already taking rasagiline or selegiline, both MAO-B inhibitors, it's generally a good idea to stop them two weeks before starting mucuna, just to be safe. Your doctor might also want to reduce your dopamine agonist medications if you're on them.


In any case, when you start mucuna, it'll be at low doses (we suggest MacuDopa - 700 mg / 63% formula) at first. Your doctor will gradually increase this based on how you respond. Your treatment plan should always be a team effort, with you and your doctor working together to find the best approach for your unique needs.

'Living well naturally with Parkinson's until there is a cure.'

  • MacuDopa Facebook page
  • MacuDopa Twitter X Account

Email us: hello@macudopa.com

Call or text us:  +44 (0) 7931 293 934 

Monday to Friday 9am to 5pm UK time

 
DISCLAIMER
​This website is for customers in the United States of America and worldwide ONLY. If you are a UK citizen looking to buy Macudopa please visit our UK site.
All the information included on this website is for information purposes only. It is not intended to treat or diagnose any medical condition, nor is it intended as a substitute for medical advice. We do not suggest using Mucuna pruriens to treat Parkinson's unless prescribed by your medical professional. If you are concerned about any symptoms please visit your doctor for investigation and diagnosis. For medical diagnosis and treatment please consult your specialist or doctor. The statements regarding Mucuna have not been evaluated by the Food and Drug Administration. These product is not intended to diagnose, treat, cure, or prevent any disease.
© 2025 CogniBrain LTD. All rights reserved.
The content provided in connection with MacuDopa, including but not limited to text, product descriptions, research summaries, FAQs, and proprietary information regarding our Mucuna-based formulation, is protected under copyright law. Unauthorized use, reproduction, or distribution of any part of this content is prohibited without prior written permission from CogniBrain LTD. MacuDopa and related intellectual property are the sole property of CogniBrain LTD, and any infringement will be pursued to the fullest extent permitted by law.
bottom of page